Michael Gould to Interleukin-2
This is a "connection" page, showing publications Michael Gould has written about Interleukin-2.
Connection Strength
0.033
-
Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. Blood. 1995 Nov 01; 86(9):3287-94.
Score: 0.033